Abstract 109: Thrombectomy is Safe for Dawn- and Defuse-3-Ineligible Patients Who Present Within the Extended Window: A Subgroup Analysis From the BEST Prospective Cohort Study

Amy Starosciak; Felipe De Los Rios La Rosa

Abstract 109: Thrombectomy is Safe for Dawn- and Defuse-3-Ineligible Patients Who Present Within the Extended Window: A Subgroup Analysis From the BEST Prospective Cohort Study

Amy Starosciak, Felipe De Los Rios La Rosa

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Stroke
Volume	50
State	Published - Feb 1 2019

Disciplines

Analytical, Diagnostic and Therapeutic Techniques and Equipment
Cardiology
Cardiovascular Diseases
Diseases
Medicine and Health Sciences
Nervous System Diseases
Neurology
Surgical Procedures, Operative

Cite this

@article{f10c8ecbf54e4d778c834be51e45cf6a,

title = "Abstract 109: Thrombectomy is Safe for Dawn- and Defuse-3-Ineligible Patients Who Present Within the Extended Window: A Subgroup Analysis From the BEST Prospective Cohort Study",

author = "Amy Starosciak and \{De Los Rios La Rosa\}, Felipe",

note = "Stroke (2019) 50(Suppl 1):A109",

year = "2019",

month = feb,

day = "1",

language = "American English",

volume = "50",

journal = "Stroke",

}

TY - JOUR

T1 - Abstract 109: Thrombectomy is Safe for Dawn- and Defuse-3-Ineligible Patients Who Present Within the Extended Window: A Subgroup Analysis From the BEST Prospective Cohort Study

AU - Starosciak, Amy

AU - De Los Rios La Rosa, Felipe

N1 - Stroke (2019) 50(Suppl 1):A109

PY - 2019/2/1

Y1 - 2019/2/1

UR - https://scholarlycommons.baptisthealth.net/se-all-publications/3131

M3 - Article

VL - 50

JO - Stroke

JF - Stroke

ER -

Abstract 109: Thrombectomy is Safe for Dawn- and Defuse-3-Ineligible Patients Who Present Within the Extended Window: A Subgroup Analysis From the BEST Prospective Cohort Study

Disciplines

Other files and links

Cite this